298 related articles for article (PubMed ID: 32677993)
1. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.
Shigemizu D; Mori T; Akiyama S; Higaki S; Watanabe H; Sakurai T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Jul; 12(1):87. PubMed ID: 32677993
[TBL] [Abstract][Full Text] [Related]
2. Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data.
Shigemizu D; Akiyama S; Higaki S; Sugimoto T; Sakurai T; Boroevich KA; Sharma A; Tsunoda T; Ochiya T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Nov; 12(1):145. PubMed ID: 33172501
[TBL] [Abstract][Full Text] [Related]
3. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
Jemimah S; AlShehhi A;
BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
[TBL] [Abstract][Full Text] [Related]
4. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
5. Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.
Khajehpiri B; Moghaddam HA; Forouzanfar M; Lashgari R; Ramos-Cejudo J; Osorio RS; Ardekani BA;
J Alzheimers Dis; 2022; 85(2):837-850. PubMed ID: 34864679
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through immune landscape analysis.
Shigemizu D; Akiyama S; Mitsumori R; Niida S; Ozaki K
NPJ Aging; 2022 Nov; 8(1):15. PubMed ID: 36333348
[TBL] [Abstract][Full Text] [Related]
8. Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
Dobromyslin VI; Megherbi DB;
J Alzheimers Dis; 2022; 87(2):583-594. PubMed ID: 35311706
[TBL] [Abstract][Full Text] [Related]
9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
10. Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study.
Roed L; Grave G; Lindahl T; Rian E; Horndalsveen PO; Lannfelt L; Nilsson C; Swenson F; Lönneborg A; Sharma P; Sjögren M
J Alzheimers Dis; 2013; 35(3):611-21. PubMed ID: 23478308
[TBL] [Abstract][Full Text] [Related]
11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
12. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
13. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
[TBL] [Abstract][Full Text] [Related]
14. Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease.
Upadhyaya Y; Xie L; Salama P; Cao S; Nho K; Saykin AJ; Yan J; Alzheimer's Disease Neuroimaging Initiative FT
BMC Med Genomics; 2020 Apr; 13(Suppl 5):53. PubMed ID: 32241275
[TBL] [Abstract][Full Text] [Related]
15. Related genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray.
Lin H; Zhang T; Wu Y; Wang Y; Wang W; Wang Q
Am J Alzheimers Dis Other Demen; 2014 Feb; 29(1):90-5. PubMed ID: 24381135
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer's Disease Using Bioinformatics Analysis.
Yu W; Yu W; Yang Y; Lü Y
Front Aging Neurosci; 2021; 13():602781. PubMed ID: 34194312
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
[TBL] [Abstract][Full Text] [Related]
18. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
[TBL] [Abstract][Full Text] [Related]
19. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
Galea E; Weinstock LD; Larramona-Arcas R; Pybus AF; Giménez-Llort L; Escartin C; Wood LB
Neurobiol Dis; 2022 May; 166():105655. PubMed ID: 35143967
[TBL] [Abstract][Full Text] [Related]
20. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
